Literature DB >> 22791499

Does endocarditis require routine coagulation screening?

Mohammad Alkhalil1, Stephen Tate.   

Abstract

We report a case of probable iatrogenic vitamin K deficiency in the context of antibiotic treatment for endocarditis. The patient was initially admitted with breathlessness and treated for an exacerbation of chronic obstructive pulmonary disease. However, during this period the patient was further diagnosed with endocarditis following repeated temperature spikes. Following initiation of antibiotic treatment for endocarditis the patient was noted to become increasingly anaemic. The patient was noted to have prolonged prothrombin time despite no anticoagulants. Antibiotics have been reported to alter the gut flora causing vitamin K deficiency; thereby, resulting in coagulopathy. We give a brief overview and literature review regarding potential vitamin K deficiency in this clinical context.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22791499      PMCID: PMC3027801          DOI: 10.1136/bcr.12.2009.2586

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Iatrogenic vitamin K deficiency and life threatening coagulopathy.

Authors:  Samuel John Ford; Alistair Webb; Richard Payne; Norbert Blesing
Journal:  BMJ Case Rep       Date:  2008-11-20

2.  [Vitamin K deficiency syndrome caused by antituberculous agents].

Authors:  F Ishii; B Iizuka; T Nakanishi; K Nagasako; N Hayashi
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1997-06

3.  Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study.

Authors:  M A Crowther; E McDonald; M Johnston; D Cook
Journal:  Blood Coagul Fibrinolysis       Date:  2002-01       Impact factor: 1.276

4.  Reduction of vitamin K2 concentrations in human liver associated with the use of broad spectrum antimicrobials.

Authors:  J Conly; K Stein
Journal:  Clin Invest Med       Date:  1994-12       Impact factor: 0.825

5.  Reversible hypoprothrombinemia in a patient with primary biliary cirrhosis treated with rifampicin.

Authors:  W Van Steenbergen; J Vermylen
Journal:  Am J Gastroenterol       Date:  1995-09       Impact factor: 10.864

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.